U.S. flag

An official website of the United States government

NM_000314.8(PTEN):c.1137T>G (p.Tyr379Ter) AND Hereditary cancer-predisposing syndrome

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 18, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001009950.3

Allele description [Variation Report for NM_000314.8(PTEN):c.1137T>G (p.Tyr379Ter)]

NM_000314.8(PTEN):c.1137T>G (p.Tyr379Ter)

Gene:
PTEN:phosphatase and tensin homolog [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
10q23.31
Genomic location:
Preferred name:
NM_000314.8(PTEN):c.1137T>G (p.Tyr379Ter)
HGVS:
  • NC_000010.11:g.87965397T>G
  • NG_007466.2:g.106959T>G
  • NM_000314.8:c.1137T>GMANE SELECT
  • NM_001304717.5:c.1656T>G
  • NM_001304718.2:c.546T>G
  • NP_000305.3:p.Tyr379Ter
  • NP_001291646.4:p.Tyr552Ter
  • NP_001291647.1:p.Tyr182Ter
  • LRG_311t1:c.1137T>G
  • LRG_311:g.106959T>G
  • NC_000010.10:g.89725154T>G
  • NM_000314.4:c.1137T>G
Protein change:
Y182*
Links:
dbSNP: rs1295420243
NCBI 1000 Genomes Browser:
rs1295420243
Molecular consequence:
  • NM_000314.8:c.1137T>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001304717.5:c.1656T>G - nonsense - [Sequence Ontology: SO:0001587]
  • NM_001304718.2:c.546T>G - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001170083Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Likely pathogenic
(Sep 18, 2019)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.

Georgescu MM, Kirsch KH, Akagi T, Shishido T, Hanafusa H.

Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10182-7.

PubMed [citation]
PMID:
10468583
PMCID:
PMC17863

Phosphorylation of the PTEN tail regulates protein stability and function.

Vazquez F, Ramaswamy S, Nakamura N, Sellers WR.

Mol Cell Biol. 2000 Jul;20(14):5010-8.

PubMed [citation]
PMID:
10866658
PMCID:
PMC85951
See all PubMed Citations (5)

Details of each submission

From Ambry Genetics, SCV001170083.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

The p.Y379* variant (also known as c.1137T>G), located in coding exon 9 of the PTEN gene, results from a T to G substitution at nucleotide position 1137. This changes the amino acid from a tyrosine to a stop codon within coding exon 9. This stop codon occurs at the 3' terminus of PTEN, is not expected to trigger nonsense-mediated mRNA decay, and impacts only the last 25 amino acids of the protein. Experimental literature points to this region being crucial for regulation of PTEN activity (Georgescu MM et al. Proc. Natl. Acad. Sci. U.S.A., 1999 Aug;96:10182-7; Hopkins BD et al. Trends Biochem. Sci., 2014 Apr;39:183-90; Sun Z et al. Cell Rep, 2014 Mar;6:844-54; Vazquez F et al. Mol. Cell. Biol., 2000 Jul;20:5010-8). Based on the majority of available evidence to date, this variant is likely to be pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024